Bayer Posts Profit Growth on Crop Science, New Drugs

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Take our Survey

November 12, 2025 at 6:51 AM UTC

Updated on

November 12, 2025 at 11:41 AM UTC

Bayer AG posted an improvement in profit, helped by surprising strength at its crop science business and demand for new drugs.

Adjusted third-quarter earnings rose to €1.51 billion ($1.75 billion) before interest, taxes, depreciation and amortization, Bayer said Wednesday. That exceeded the €1.29 billion estimate of analysts.